| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ATX | Ann: Managing Director's Presentation to AGM | 13:27 | 66 | 13K | |||
|
|||||||
| ATX | Ann: Notification of cessation of securities - ATX | 02/09/25 | 0 | 252 | |||
|
|||||||
| ATX | Ann: AUSTRALIAN TRIAL SITES OPEN FOR NEW NARMAFOTINIB TRIAL | 02/09/25 | 7 | 2.3K | |||
|
|||||||
| ATX | Ann: NARMAFOTINIB ADOPTED AS NONPROPRIETARY DRUG NAME IN USA | 02/09/25 | 3 | 792 | |||
|
|||||||
| ATX | Ann: Notification regarding unquoted securities - ATX | 01/09/25 | 0 | 151 | |||
|
|||||||
| ATX | Ann: Notification regarding unquoted securities - ATX | 01/09/25 | 1 | 233 | |||
|
|||||||
| ATX | Ann: Notice under Section 708A(5)(e) of the Corporations Act | 01/09/25 | 0 | 155 | |||
|
|||||||
| ATX | Ann: Application for quotation of securities - ATX | 01/09/25 | 0 | 124 | |||
|
|||||||
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $82.09M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.8¢ | 16.0¢ | $110.3K | 678.6K |
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 1383859 | 16.0¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 12242 | 1 |
| Last trade - 16.10pm 03/09/2025 (20 minute delay) ? |
|
|||||
|
Last
16.3¢ |
Change
-0.010 ( 2.99 %) |
||||
| Open | High | Low | Volume | ||
| 16.5¢ | 17.0¢ | 16.0¢ | 717418 | ||
| Last updated 15.59pm 03/09/2025 ? | |||||
| ATX (ASX) Chart |
ASX News
